Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.
It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.
During physical examination, vital signs are monitored, and a cardiovascular exam is performed to look for signs of heart failure, heart murmurs, and abnormal heart sounds.
Essential diagnostic tools include the 12-lead ECG, which should be performed within 10 minutes of patient presentation to identify changes such as T-wave inversion, ST-segment elevation, and abnormal Q waves. The prompt execution of a 12-lead ECG within this timeframe is critical because rapid identification of these changes can significantly impact the timely initiation of life-saving treatments and interventions, reducing the risk of severe complications and improving patient outcomes.
Laboratory tests are essential for diagnosing ACS, particularly measuring cardiac biomarkers. Cardiac biomarkers are crucial in diagnosing and managing heart attacks. When the heart is under severe stress or injured due to inadequate oxygen, these biomarkers appear in the blood. Troponins (I and T) are the most reliable and sensitive indicators of a heart attack, appearing within 3-6 hours, peaking at 12-24 hours, and remaining elevated for up to two weeks. The American Heart Association (AHA) recommends using troponins as the primary diagnostic tool. Creatine kinase (CK) and its subtype CK-MB also rise after a heart attack but are less specific, with CK-MB appearing within 4-6 hours and normalizing within 48-72 hours. Myoglobin, an oxygen-storing protein, rises quickly within 1-3 hours and peaks at 8-12 hours but lacks specificity, making it less useful.
Other laboratory examinations, including complete blood count (CBC), lipid profile, blood glucose, HbA1c, and renal function tests, are essential for assessing cardiovascular risk factors, ruling out anemia or infection, and evaluating renal function prior to certain treatments.
Imaging studies further aid in the diagnosis and management of ACS.
Assessing acute coronary syndrome begins with a detailed patient history, focusing on chest pain characteristics, previous cardiac history, family history of heart disease, and risk factors, including obesity, smoking, and hyperlipidemia.
During the physical examination, vital signs are checked for abnormalities and heart failure symptoms, such as jugular venous distention and peripheral edema.
Auscultation may reveal new murmurs suggesting mitral regurgitation or a ventricular septal defect, while the respiratory examination assesses rales or crackles indicating pulmonary congestion.
Diagnostic studies, including a 12-lead ECG, can show ST elevation, indicating STEMI; ST depression and T-wave inversion, suggesting NSTEMI; and abnormal Q waves from necrosis.
Cardiac biomarkers, including Troponin I and T, appear in the blood 3-4 hours after heart injury.
Creatine kinase-MB is detected in 3-6 hours, and myoglobin rises in 1-3 hours.
Lastly, imaging studies, like echocardiography, evaluate left ventricular function and wall motion. Coronary angiography identifies arterial blockages.
繁體中文
